Stock events for Utah Medical Products, Inc. (UTMD)
Over the past six months, UTMD's stock price has experienced some fluctuations. As of November 18, 2025, the share price was $54.63, representing a decline of 9.61% over the past 30 days and 16.89% over the past 12 months. Specific events impacting the stock price include the release of third-quarter 2025 earnings, which were down year-over-year due to trade disruptions and margin squeeze, and the announcement of quarterly dividends.
Demand Seasonality affecting Utah Medical Products, Inc.’s stock price
The search results do not contain specific information regarding the demand seasonality for Utah Medical Products, Inc.'s products and services.
Overview of Utah Medical Products, Inc.’s business
Utah Medical Products, Inc. (UTMD), established in 1978, is a leading developer, manufacturer, and marketer of specialized medical devices focused on women's and newborn's health. The company's product portfolio includes infusion therapy, labor and delivery, neonatal intensive care, urological devices, electrosurgery, blood pressure monitoring, women's pelvic health, and components and sub-assemblies.
UTMD’s Geographic footprint
Utah Medical Products, Inc. serves hospitals, clinics, and distributors across North America, Europe, Asia, and other international markets. The company's products are recognized by healthcare professionals in over a hundred countries worldwide.
UTMD Corporate Image Assessment
Utah Medical Products, Inc. has built its reputation on a history of innovation, delivering high-quality, reliable solutions, and a commitment to quality standards and regulatory compliance. The company aims to provide safe and effective products that help medical professionals achieve optimal health outcomes while minimizing healthcare costs. No specific events negatively impacted the brand reputation in the past year.
Ownership
Utah Medical Products, Inc. has a significant number of institutional owners and shareholders. As of recent filings, 265 institutional owners and shareholders have filed 13D/G or 13F forms, holding a total of 2,717,300 shares. Major institutional owners include Brandes Investment Partners, Lp, Renaissance Technologies Llc, and Dimensional Fund Advisors Lp.
Ask Our Expert AI Analyst
Price Chart
$55.52
